Company Filing History:
Years Active: 2006-2012
Title: Angelica Linton: Innovator in Hepatitis C Treatment
Introduction
Angelica Linton is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of pharmaceutical sciences. With a focus on developing treatments for viral infections, she has been instrumental in advancing medical research and innovation. Linton holds a total of 3 patents that reflect her dedication to improving healthcare outcomes.
Latest Patents
Among her latest patents, Linton has developed inhibitors of hepatitis C virus RNA-dependent RNA polymerase. These inventions provide compounds that are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme. The compounds, along with their pharmaceutically acceptable salts and solvates, are designed for the treatment of HCV infections in infected mammals. Additionally, her patents include pharmaceutical compositions comprising these compounds, as well as intermediate compounds and methods useful in their preparation.
Career Highlights
Throughout her career, Angelica Linton has worked with leading pharmaceutical companies, including Pfizer Corporation and Agouron Pharmaceuticals, Inc. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her expertise in drug development.
Collaborations
Linton has had the opportunity to work alongside talented colleagues such as Javier Gonzalez and Tanya Michelle Jewell. These collaborations have contributed to her innovative approach to research and development in the pharmaceutical field.
Conclusion
Angelica Linton's work in developing treatments for hepatitis C showcases her commitment to innovation in healthcare. Her patents and collaborations highlight her significant impact on the pharmaceutical industry, paving the way for future advancements in medical treatments.